Merck KGaA
MKGAF
$143.70
-$1.66-1.14%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Net Income | 3.01B | 2.93B | 2.84B | 2.95B | 3.06B |
Total Depreciation and Amortization | 1.86B | 1.86B | 1.84B | 1.83B | 1.83B |
Total Amortization of Deferred Charges | 117.26M | 111.96M | 111.96M | 111.96M | 111.96M |
Total Other Non-Cash Items | 312.81M | 255.33M | 177.90M | -175.31M | -144.09M |
Change in Net Operating Assets | -329.53M | -363.71M | -417.99M | -426.33M | -762.76M |
Cash from Operations | 4.97B | 4.79B | 4.55B | 4.30B | 4.09B |
Capital Expenditure | -1.84B | -1.96B | -1.92B | -1.91B | -1.95B |
Sale of Property, Plant, and Equipment | 29.66M | 39.26M | 23.83M | 20.64M | 19.42M |
Cash Acquisitions | -843.57M | -612.28M | -13.03M | -13.03M | -13.03M |
Divestitures | 7.58M | 6.51M | 6.51M | 6.51M | -- |
Other Investing Activities | -671.32M | -606.70M | 259.80M | 429.74M | -89.04M |
Cash from Investing | -3.32B | -3.13B | -1.65B | -1.46B | -2.03B |
Total Debt Issued | 2.83B | 1.99B | 1.26B | 1.22B | 1.43B |
Total Debt Repaid | -2.91B | -1.76B | -1.96B | -2.06B | -2.00B |
Issuance of Common Stock | -- | -- | -- | -- | -- |
Repurchase of Common Stock | -- | -- | -- | -- | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -1.11B | -1.11B | -1.11B | -1.21B | -1.25B |
Other Financing Activities | 127.00M | 89.00M | -10.00M | -10.00M | -11.00M |
Cash from Financing | -1.03B | -752.98M | -1.88B | -2.12B | -1.88B |
Foreign Exchange rate Adjustments | -17.55M | -33.66M | -18.30M | -18.36M | -33.34M |
Miscellaneous Cash Flow Adjustments | 2.17M | 2.19M | -2.50K | 1.07M | -11.80K |
Net Change in Cash | 595.69M | 869.84M | 1.00B | 696.11M | 148.19M |